Data

#3D modelling #Antibiotics #Biotechnology #Cell / tissue culture #Data #Drug discovery #Drug targets #Drug technology #Imaging

How imaging techniques are innovating drug discovery

Lu Rahman takes look at some of the latest imaging innovation available and how it can benefit drug target identification and drug discovery research. Imaging is an important element within the drug discovery and development process providing researchers with information that can help identify potential drug targets or see how… Read More

#Exclusive Content #News #Trends & Analysis

#Data #Diabetes #GlobalData #Research #Therapeutics

Global diabetes therapeutic market has grown sixfold in last 20 years

According to GlobalData, the diabetes market has gone through significant maturation, attributed to increased innovation and modernisation of therapeutic treatments over the past 20 years. The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to continue increasing in… Read More

#News

#AI / data analytics / healthtech / informatics #Data #Database #Pharmaceuticals

Pharmaceutical companies lack digital ability

Nearly half of pharmaceutical companies (48%) admit their competitiveness suffers because they cannot extract or use insights from data they already have within their business. An equal percentage (48%) admit they do not use their own data for business decisions as well as they could. The findings are from research… Read More

#News

#Assay #Bioscience #Data #Drug discovery #Drug targets #Interview #Life sciences #Screening

Ask the expert: assisting researchers with hit-to-lead

Pelago Bioscience is a specialised CRO, focusing on its patented Cellular Thermal Shift Assay (CETSA), which can assess therapeutically relevant target engagement in cells or tissue of unmodified compounds against the native, full-length proteins of interest. Stina Lundgren, Principal Project Advisor, shared the company’s hit-to-lead expertise with Lu Rahman. CETSA… Read More

#Editor's Choice #Exclusive Content #News

#Biotechnology #Data #Research

Vizgen advances spatial genomics research

Vizgen has released its first freely available dataset, the Vizgen MERFISH Mouse Brain Receptor Map. This is reportedly the first of a series of datasets that will be made available through the company’s new Data Release Program. The MERFISH release is said to mark the first time the research community… Read More

#News

#Data #Drug development #Drug repurposing #Drug research

In vitro drug interaction data critical in drug repurposing

Listen to this article on the DDW Podcast: In the wake of Covid-19 interest in repurposing a drug for a different indication to the one it was developed for has been high. Madison Knapp, Marketing Communications Specialist, and Dr. Brian Ogilvie, Vice President of Scientific Consulting, SEKISUI XenoTech offer… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion

#Clinical trial #Covid-19 #Data

Clinical trials impacted by slow enrolment

The surge in new variants for Covid-19 and an increase in subsequent cases is continuing to have an impact on clinical trials, while still allowing them to resume. The total number of disrupted trials has levelled off, but the number of clinical trials that have resumed continues to rise, although… Read More

#News

#Data #Drug development #Drug discovery

China’s fast-track regulatory reforms not attracting non-Chinese companies

China has reformed its regulatory system in recent years to include various fast-track programs similar to the US, EU and Japan to incentivise the development of drugs for unmet medical needs and serious conditions. However, only a few companies based outside of China have been granted priority review status by… Read More

#News

#Clinical trial #Clinical trials #Data #Sitting Down With

What has the pandemic taught us about clinical trials?

The latest DDW Sponsored Sitting Down With podcast features Raj Indupuri, CEO of eClinical Solutions, and he talks to us about clinical trials. Listen to this podcast to find out why Indupuri believes ‘data is the new fuel that will drive human progress’, the effect of Covid-19 on clinical trials… Read More

#Podcasts

#Covid-19 #Data #Drug delivery #Drug development #Drug discovery #Research

Interim data suggests drug may prevent cytokine storm

Clinical-stage drug development company Noxopharm has announced that in a cohort of 18 patients with moderately severe cases of Covid-19, interim data from its NOXCOVID study suggests Veyonda provides protection against progression of the severe inflammation associated with the worsening of the virus. “Until enough people are vaccinated to achieve… Read More

#News

#Biopharmaceuticals #Data #Drug development #Life sciences

Price control could cut medicine development by 88% in California

Researchers from Biocom California and the California Life Sciences Association (CLSA) have released data analysing the potential impact of international reference pricing (foreign price controls) on California’s biopharmaceutical innovation ecosystem, including investment into small company capital formation and the new drug development pipeline. The analysis shows that implementing foreign reference… Read More

#News

#Assays #Biologics / Biotechnology #Covid-19 #Data

GSK and Vir Biotechnology request for EUA for COVID-19 treatment

GlaxoSmithKline (GSK) and Vir Biotechnology have announced the submission of an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorisation (EUA) for VIR-7831 (GSK4182136), an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and older weighing at least 40… Read More

#Covid-19 #News

#AI / data analytics / healthtech / informatics #Clinical trial #Data #Drug development #Drug discovery #Report

Report promotes the use of synthetic data in clinical trials

Phesi, provider of AI-powered clinical development analytics products and solutions, and Accenture, a services and consulting company, have released the first of a series of reports exploring the use of synthetic data in clinical development. In recent years, the volume of data created through clinical trials and electronic patient records… Read More

#News

#Covid-19 #Data #Research & development

How to achieve data-driven R&D at speed

COVID-19 has shown the pace of innovation that is possible to develop vaccines and therapeutics. Matt Jones, Lead Data Scientist Strategist, Tessella explains how to set up R&D and data science teams to keep that going. The drive to develop new therapeutics and vaccines for COVID-19 saw researchers move at… Read More

#Business & Investment